Transparency Phase III: FDA Offers Designs For Industry Review
You may also be interested in...
Vanda Sues US FDA For Documents Backing Complete Response For Hetlioz Jet Lag Indication
FOIA exemption does not apply to medical and statistical reviews of its sNDA, company claims. It says it needs the information to adapt its development program and determine if the agency made an error.
FDA, CMS To Standardize Regulatory Analytical Tools
FDA, CMS and other agencies within the Department of Health and Human Services will combine forces to improve and standardize analytical tools used in regulatory decision-making.
FDA, CMS To Standardize Regulatory Analytical Tools
FDA, CMS and other agencies within the Department of Health and Human Services will combine forces to improve and standardize analytical tools used in regulatory decision-making.